Legato Capital Management LLC Invests $443,000 in CryoPort, Inc. $CYRX

Legato Capital Management LLC acquired a new stake in shares of CryoPort, Inc. (NASDAQ:CYRX) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 46,188 shares of the company’s stock, valued at approximately $443,000. Legato Capital Management LLC owned approximately 0.09% of CryoPort as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC lifted its stake in CryoPort by 300.1% in the second quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after acquiring an additional 4,375 shares during the last quarter. Whittier Trust Co. of Nevada Inc. acquired a new stake in shares of CryoPort in the third quarter worth $53,000. AlphaQuest LLC acquired a new stake in shares of CryoPort in the third quarter worth $79,000. Creative Planning acquired a new stake in shares of CryoPort in the second quarter worth $96,000. Finally, State of Wyoming lifted its stake in shares of CryoPort by 30.2% in the second quarter. State of Wyoming now owns 14,218 shares of the company’s stock worth $106,000 after buying an additional 3,301 shares during the last quarter. 92.90% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CryoPort

In other news, CFO Robert Stefanovich sold 38,700 shares of the firm’s stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $7.76, for a total transaction of $300,312.00. Following the completion of the transaction, the chief financial officer directly owned 255,701 shares of the company’s stock, valued at $1,984,239.76. This trade represents a 13.15% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mark W. Sawicki sold 3,235 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $8.00, for a total transaction of $25,880.00. Following the transaction, the insider directly owned 103,697 shares of the company’s stock, valued at $829,576. This represents a 3.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 59,939 shares of company stock valued at $471,183 in the last ninety days. 10.00% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CYRX shares. BTIG Research boosted their price objective on shares of CryoPort from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Tuesday, May 5th. Craig Hallum started coverage on shares of CryoPort in a research report on Monday, March 30th. They set a “buy” rating and a $15.00 target price on the stock. Needham & Company LLC boosted their target price on shares of CryoPort from $13.00 to $15.00 and gave the stock a “buy” rating in a research report on Tuesday, May 5th. Guggenheim boosted their target price on shares of CryoPort from $11.00 to $12.00 and gave the stock a “buy” rating in a research report on Tuesday, May 5th. Finally, Wall Street Zen raised shares of CryoPort from a “sell” rating to a “hold” rating in a research report on Monday, May 11th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $14.69.

CryoPort Trading Up 0.4%

CryoPort stock opened at $14.02 on Thursday. CryoPort, Inc. has a 1 year low of $5.31 and a 1 year high of $14.36. The company has a market cap of $706.61 million, a PE ratio of 10.39 and a beta of 1.75. The company’s 50-day moving average is $10.68 and its two-hundred day moving average is $9.77.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Monday, May 4th. The company reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.03). The firm had revenue of $47.80 million during the quarter, compared to analyst estimates of $44.86 million. CryoPort had a net margin of 41.57% and a negative return on equity of 7.92%. Research analysts forecast that CryoPort, Inc. will post -0.74 EPS for the current year.

About CryoPort

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.